High-content affinity-based proteomics: unlocking protein biomarker discovery

References

• Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science306(5696), 640–643 (2004).
   PubMed Web of Science ®Google Scholar
• Bueno-de-Mesquita JM, van Harten WH, Retel VP et al. Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol.8(12), 1079–1087 (2007).
   PubMed Web of Science ®Google Scholar
• Cardoso F, Van’t Veer L, Rutgers E et al. Clinical application of the 70-gene profile: the MINDACT trial. J. Clin. Oncol.26(5), 729–735 (2008).
   PubMed Web of Science ®Google Scholar
• Knauer M, Mook S, Rutgers EJ et al. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res. Treat.120(3), 655–661 (2010).
   PubMed Web of Science ®Google Scholar
• Mamounas EP, Tang G, Fisher B et al. Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J. Clin. Oncol.28(10), 1677–1683 (2010).
   PubMed Web of Science ®Google Scholar
• Lo SS, Mumby PB, Norton J et al. Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J. Clin. Oncol.28(10), 1671–1676 (2010).
   PubMed Web of Science ®Google Scholar
• Albain KS, Barlow WE, Shak S et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol.11(1), 55–65 (2010).
   PubMed Web of Science ®Google Scholar
• Gilad S, Meiri E, Yogev Y et al. Serum microRNAs are promising novel biomarkers. PloS ONE3(9) e3148 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenfeld N, Aharonov R, Meiri E et al. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol.26(4), 462–469 (2008).
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Chang P et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res.2(9), 807–813 (2009).
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med.351(27), 2817–2826 (2004).
   PubMed Web of Science ®Google Scholar
• Zichi D, Eaton B, Singer B, Gold L. Proteomics and diagnostics: let’s get specific, again. Curr. Opin. Chem. Biol.12(1), 78–85 (2008).
   PubMed Web of Science ®Google Scholar
• de Sousa Abreu R, Penalva LO, Marcotte EM, Vogel C. Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Mol. Biosyst.5(12), 1512–1526 (2009).
   PubMed Web of Science ®Google Scholar
• Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science324(5924), 218–223 (2009).
   PubMed Web of Science ®Google Scholar
• Pascal LE, True LD, Campbell DS et al. Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics9, 246 (2008).
   PubMed Web of Science ®Google Scholar
• Guo Y, Xiao P, Lei S et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim. Biophys. Sin.40(5), 426–436 (2008).
   Google Scholar
• Lu P, Vogel C, Wang R, Yao X, Marcotte EM. Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol.25(1), 117–124 (2007).
   PubMed Web of Science ®Google Scholar
• Baek D, Villén J, Shin C et al. The impact of microRNAs on protein output. Nature455(7209), 64–71 (2008).
   PubMed Web of Science ®Google Scholar
• Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev. Cell18(4), 510–525 (2010).
   PubMed Web of Science ®Google Scholar
• Williams AH, Valdez G, Moresi V et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science326(5959), 1549–1554 (2009).
   PubMed Web of Science ®Google Scholar
• Mattick JS. RNA as the substrate for epigenome–environment interactions: RNA guidance of epigenetic processes and the expansion of RNA editing in animals underpins development, phenotypic plasticity, learning, and cognition. BioEssays32(7), 548–552 (2010).
   PubMedGoogle Scholar
• Selbach M, Schwanhäusser B, Thierfelder N et al. Widespread changes in protein synthesis induced by microRNAs. Nature455(7209), 58–63 (2008).
   PubMed Web of Science ®Google Scholar
• Roth A, Breaker RR. The structural and functional diversity of metabolite-binding riboswitches. Ann. Rev. Biochem.78, 305–334 (2009).
   PubMed Web of Science ®Google Scholar
• Weinberg Z, Perreault J, Meyer MM, Breaker RR. Exceptional structured noncoding RNAs revealed by bacterial metagenome analysis. Nature462(7273), 656–659 (2009).
   PubMed Web of Science ®Google Scholar
• Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J. Natl Cancer Inst.102(7), 464–474 (2010).
   PubMed Web of Science ®Google Scholar
• Pass HI, Goparaju C, Ivanov S et al. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res.70(5), 1916–1924 (2010).
   PubMed Web of Science ®Google Scholar
• Ferracin M, Veronese A, Negrini M. Micromarkers: miRNAs in cancer diagnosis and prognosis. Expert Rev. Mol. Diagn.10(3), 297–308 (2010).
   PubMed Web of Science ®Google Scholar
• Rosenwald S, Gilad S, Benjamin S et al. Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod. Pathol.23(6), 814–823 (2010).
   PubMed Web of Science ®Google Scholar
• International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature431(7011), 931–945 (2005).
   Google Scholar
• Morozova O, Hirst M, Marra MA. Applications of new sequencing technologies for transcriptome analysis. Annu. Rev. Genomics Hum. Genet.10, 135–151 (2009).
   PubMed Web of Science ®Google Scholar
• Lashkari DA, DeRisi JL, McCusker JH et al. Yeast microarrays for genome wide parallel genetic and gene expression analysis. Proc. Natl Acad. Sci. USA94(24), 13057–13062 (1997).
   PubMed Web of Science ®Google Scholar
• Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science270(5235), 467–470 (1995).
   PubMed Web of Science ®Google Scholar
• Mardis ER. Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet.9, 387–402 (2008).
   PubMed Web of Science ®Google Scholar
• Goetz T. Sergey Brin’s search for a Parkinson’s cure. Wired22, 107–113 (2010).
   Google Scholar
• Glass DJ. A critique of the hypothesis, and a defense of the question, as a framework for experimentation. Clin. Chem.56(7), 1080–1085 (2010).
   PubMed Web of Science ®Google Scholar
• Nabel GJ. The coordinates of truth. Science326, 53–54 (2009).
   PubMedGoogle Scholar
• Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. BioEssays26(1), 99–105 (2004).
   PubMed Web of Science ®Google Scholar
• Lander AD. The edges of understanding. BMC Biol.8, 40 (2010).
   PubMed Web of Science ®Google Scholar
• O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250(10), 4007–4021 (1975).
   PubMed Web of Science ®Google Scholar
• Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring – based measurements of proteins in plasma. Nat. Biotechnol.27(7), 633–641 (2009).
   PubMed Web of Science ®Google Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24(8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Parker CE, Pearson TW, Anderson NL, Borchers CH. Mass-spectrometry-based clinical proteomics – a review and prospective. Analyst135(8), 1830–1838 (2010).
   PubMed Web of Science ®Google Scholar
• Oudin J. Methode d’analyze immunochimique par precipitation specifique en milieu gelifie. CR Acad. Sci. Paris222, 115–116 (1946).
   Google Scholar
• Ouchterlony O. Antigen-antibody reactions in gels. Acta Path. Microbiol. Scand.26(4), 507–515 (1949).
   PubMedGoogle Scholar
• Ouchterlony O. In vitro method for testing the toxinproducing capacity of diphtheria bacteria. Acta Pathol. Microbiol. Scand.26(4), 516–524 (1949).
   PubMedGoogle Scholar
• Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest.39, 1157–1175 (1960).
   PubMed Web of Science ®Google Scholar
• Wide L, Porath J. Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies. Biochem. Biophys. Acta30, 247–260 (1966).
   Google Scholar
• Nakane P, Pierce G. Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens. J. Cell. Biol. (33), 307–318 (1967).
   PubMedGoogle Scholar
• Avrameas S, Uriel J. Methode de marquage d’antigenes et d’anticorps avec des enzymes et son application en immunodiffusion. CR Acad. Sci. Paris262, 2543–2545 (1966).
   Google Scholar
• VanWeeman B, Schuurs A. Immunoassay using antigen-enzyme conjugates. FEBS Lett.15(3), 232–236 (1971).
   PubMedGoogle Scholar
• Engvall E, Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry8, 871–874 (1971).
   PubMedGoogle Scholar
• Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol.2(2), research0004 (2001).
   PubMedGoogle Scholar
• Schröder C, Jacob A, Tonack S et al. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol. Cell. Proteomics9(6), 1271–1280 (2010).
   PubMed Web of Science ®Google Scholar
• Borrebaeck CA, Wingren C. Design of high-density antibody microarrays for disease proteomics: key technological issues. J. Proteomics72(6), 928–935 (2009).
   PubMed Web of Science ®Google Scholar
• Borrebaeck CA, Wingren C. High-throughput proteomics using antibody microarrays: an update. Expert Rev. Mol. Diagn.7(5), 673–686 (2007).
   PubMed Web of Science ®Google Scholar
• Seurynck-Servoss SL, White AM, Baird CL, Rodland KD, Zangar RC. Evaluation of surface chemistries for antibody microarrays. Anal. Biochem.371(1), 105–115 (2007).
   PubMed Web of Science ®Google Scholar
• Schweitzer B, Roberts S, Grimwade B et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol.20(4), 359–365 (2002).
   PubMed Web of Science ®Google Scholar
• Sun H, Chua M, Yang D et al. Antibody arrays identify potential diagnostic markers of hepatocellular carcinoma. Biomarker Insights3, 1–18 (2008).
   PubMedGoogle Scholar
• Fredriksson S, Dixon W, Ji H et al. Multiplexed protein detection by proximity ligation for cancer biomarker validation. Nat. Methods4(4), 327–329 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson NL. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1(11), 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Domenici E, Willé DR, Tozzi F et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case–control collections. PloS ONE5(2) e9166 (2010).
   PubMed Web of Science ®Google Scholar
• Kim BK, Lee JW, Park PJ et al. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res.11(2), R22 (2009).
   PubMed Web of Science ®Google Scholar
• Rissin DM, Kan CW, Campbell TG et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol.28(6), 595–599 (2010).
   PubMed Web of Science ®Google Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science249(4968), 505–510 (1990).
   PubMed Web of Science ®Google Scholar
• Ellington A, Szostak J. In vitro selection of RNA molecules that bind specific ligands. Nature346(6287), 818–822 (1990).
   PubMed Web of Science ®Google Scholar
• Gold L, Ayers D, Bertino J et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS ONE (2010) (In press)
   Google Scholar
• Ostroff R, Bigbee W, Franklin W et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PloS ONE (2010) (In press).
   Google Scholar
• Zichi D, Koga T, Greef C, Ostroff R, Petach H. Photoaptamer technology: development of multiplexed microarray protein assays. Clin. Chem.48(10) 1865–1868 (2002).
   Google Scholar
• Smith D, Collins BD, Heil J, Koch TH. Sensitivity and specificity of photoaptamer probes. Mol. Cell. Proteomics2(1), 11–18 (2003).
   PubMed Web of Science ®Google Scholar
• Petach H. Dimensionality is the issue: use of photoaptamers in protein microarrays. Curr. Opin. Biotechnol.13(4), 309–314 (2002).
   PubMed Web of Science ®Google Scholar
• Bock C, Coleman M, Collins B et al. Photoaptamer arrays applied to multiplexed proteomic analysis. Proteomics4(3), 609–618 (2004).
   PubMed Web of Science ®Google Scholar
• Keeney TR, Bock C, Gold L et al. Automation of the SomaLogic proteomics assay: a platform for biomarker discovery. JALA14(6), 360–366 (2009).
   Google Scholar
• Ostroff R, Foreman T, Keeney TR et al. The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. J. Proteomics73(3), 649–666 (2010).
   PubMed Web of Science ®Google Scholar
• Gold L, Janjic N, Jarvis T et al. Aptamers and the RNA world, past and present. In: RNA World IV. Atkins JF, Gesteland RF, Cech T (Eds). Cold Spring Harbor Laboratory Press, NY, USA, 1–10 (2010).
   Google Scholar
• Smith D. Sensitivity and specificity of photoaptamer probes. Mol. Cell. Proteomics2(1), 11–18 (2002).
   Google Scholar
• Hopfield JJ, Yamane T, Yue V, Coutts SM. Direct experimental evidence for kinetic proofreading in amino acylation of tRNAIle. Proc. Natl Acad. Sci. USA73(4), 1164–1168 (1976).
   PubMed Web of Science ®Google Scholar
• Hopfield JJ. Kinetic proofreading: a new mechanism for reducing errors in biosynthetic processes requiring high specificity. Proc. Natl Acad. Sci. USA71(10), 4135–4139 (1974).
   PubMed Web of Science ®Google Scholar
• Vaught JD, Dewey T, Eaton BE. T7 RNA polymerase transcription with 5-position modified UTP derivatives. J. Am. Chem. Soc.126(36), 11231–11237 (2004).
   PubMed Web of Science ®Google Scholar
• Vaught JD, Bock C, Carter J et al. Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc.132(12), 4141–4151 (2010).
   PubMed Web of Science ®Google Scholar
• Huang D, Vu D, Cassiday La et al. Crystal structure of NF-κB (p50)2 complexed to a high-affinity RNA aptamer. Proc. Natl Acad. Sci. USA100(16), 9268–9273 (2003).
   PubMedGoogle Scholar
• Long SB, Long MB, White RR, Sullenger BA. Crystal structure of an RNA aptamer bound to thrombin. RNA14(12), 2504–2512 (2008).
   PubMed Web of Science ®Google Scholar
• Vicens Q, Cech TR. Atomic level architecture of group I introns revealed. Trend. Biochem. Sci.31(1), 41–51 (2006).
   PubMedGoogle Scholar
• Fredriksson S, Horecka J, Brustugun OT et al. Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer. Clin. Chem.54(3), 582–589 (2008).
   PubMed Web of Science ®Google Scholar
• Gloriam DE, Orchard S, Bertinetti D et al. A community standard format for the representation of protein affinity reagents. Mol. Cell. Proteomics9(1), 1–10 (2010).
   PubMedGoogle Scholar
• Kraemer S, Vaught JD, Bock C et al. From aptamer-based biomarker discovery to diagnostic and clinical applications: an aptamer-based, streamlined multiplex proteomic assay. Nature PrecedingsDOI: hdl:10101/npre2010.4642.1 (2010).
   Google Scholar
• Venturoli D, Rippe B. Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am. J. Physiol. Renal Physiol.288(4), F605–F613 (2005).
   PubMed Web of Science ®Google Scholar
• Vanbelleghem H, Vanholder R, Levin NW et al. The kidney disease: improving global outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int.71(10), 1054–1061 (2007).
   PubMedGoogle Scholar
• Kassis ES, Vaporciyan AA, Swisher SG et al. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J. Thorac. Cardiovasc. Surg.138(2), 412–418 (2009).
   PubMed Web of Science ®Google Scholar
• Okada M, Nishio W, Sakamoto T et al. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection. J. Thorac. Cardiovasc. Surg.129(1), 87–93 (2005).
   PubMed Web of Science ®Google Scholar
• Lin H, Lee E, Hestir K et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science320(5877), 807–811 (2008).
   PubMed Web of Science ®Google Scholar